144 related articles for article (PubMed ID: 10355741)
1. Cytotoxic analogs of luteinizing hormone-releasing hormone bind with high affinity to human breast cancers.
Halmos G; Nagy A; Lamharzi N; Schally AV
Cancer Lett; 1999 Mar; 136(2):129-36. PubMed ID: 10355741
[TBL] [Abstract][Full Text] [Related]
2. Administration of a targeted cytotoxic analog of luteinizing hormone-releasing hormone inhibits growth of estrogen-independent MDA-MB-231 human breast cancers in nude mice.
Kahán Z; Nagy A; Schally AV; Halmos G; Arencibia JM; Groot K
Breast Cancer Res Treat; 2000 Feb; 59(3):255-62. PubMed ID: 10832595
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent.
Nagy A; Schally AV; Armatis P; Szepeshazi K; Halmos G; Kovacs M; Zarandi M; Groot K; Miyazaki M; Jungwirth A; Horvath J
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7269-73. PubMed ID: 8692981
[TBL] [Abstract][Full Text] [Related]
4. Effective treatment of metastatic MDA-MB-435 human estrogen-independent breast carcinomas with a targeted cytotoxic analogue of luteinizing hormone-releasing hormone AN-207.
Chatzistamou L; Schally AV; Nagy A; Armatis P; Szepeshazi K; Halmos G
Clin Cancer Res; 2000 Oct; 6(10):4158-65. PubMed ID: 11051271
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers.
Letsch M; Schally AV; Szepeshazi K; Halmos G; Nagy A
Clin Cancer Res; 2003 Oct; 9(12):4505-13. PubMed ID: 14555524
[TBL] [Abstract][Full Text] [Related]
6. Complete regression of MX-1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207.
Kahán Z; Nagy A; Schally AV; Halmos G; Arencibia JM; Groot K
Cancer; 1999 Jun; 85(12):2608-15. PubMed ID: 10375109
[TBL] [Abstract][Full Text] [Related]
7. LH-RH receptors in human colorectal cancers: unexpected molecular targets for experimental therapy.
Szepeshazi K; Schally AV; Halmos G
Int J Oncol; 2007 Jun; 30(6):1485-92. PubMed ID: 17487370
[TBL] [Abstract][Full Text] [Related]
8. Targeted cytotoxic luteinizing hormone releasing hormone (LH-RH) anlalogs inhibit growth of estrogen independent MXT mouse mammary cancers in vivo by decreasing cell proliferation and inducing apoptosis.
Szepeshazi K; Schally AV; Nagy A; Halmos G; Groot K
Anticancer Drugs; 1997 Nov; 8(10):974-87. PubMed ID: 9436641
[TBL] [Abstract][Full Text] [Related]
9. Regulation of targeted chemotherapy with cytotoxic lutenizing hormone-releasing hormone analogue by epidermal growth factor.
Krebs LJ; Wang X; Pudavar HE; Bergey EJ; Schally AV; Nagy A; Prasad PN; Liebow C
Cancer Res; 2000 Aug; 60(15):4194-9. PubMed ID: 10945629
[TBL] [Abstract][Full Text] [Related]
10. Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits the growth of PC-82 human prostate cancer in nude mice.
Koppán M; Nagy A; Schally AV; Plonowski A; Halmos G; Arencibia JM; Groot K
Prostate; 1999 Feb; 38(2):151-8. PubMed ID: 9973101
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition of human ovarian cancers by cytotoxic analogues of luteinizing hormone-releasing hormone.
Miyazaki M; Nagy A; Schally AV; Lamharzi N; Halmos G; Szepeshazi K; Groot K; Armatis P
J Natl Cancer Inst; 1997 Dec; 89(23):1803-9. PubMed ID: 9392622
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of binding of cytotoxic analogs of luteinizing hormone-releasing hormone to human breast cancer and mouse MXT mammary tumor.
Milovanovic SR; Radulovic S; Schally AV
Breast Cancer Res Treat; 1992; 24(2):147-58. PubMed ID: 8443402
[TBL] [Abstract][Full Text] [Related]
13. Targeted cytotoxic analogue of luteinizing hormone-releasing hormone (LH-RH) only transiently decreases the gene expression of pituitary receptors for LH-RH.
Kovacs M; Schally AV; Csernus B; Busto R; Rekasi Z; Nagy A
J Neuroendocrinol; 2002 Jan; 14(1):5-13. PubMed ID: 11903807
[TBL] [Abstract][Full Text] [Related]
14. Short-chain analogs of luteinizing hormone-releasing hormone containing cytotoxic moieties.
Janáky T; Juhász A; Rékási Z; Serfözö P; Pinski J; Bokser L; Srkalovic G; Milovanovic S; Redding TW; Halmos G
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10203-7. PubMed ID: 1332035
[TBL] [Abstract][Full Text] [Related]
15. Targeting of cytotoxic luteinizing hormone-releasing hormone analogs to breast, ovarian, endometrial, and prostate cancers.
Nagy A; Schally AV
Biol Reprod; 2005 Nov; 73(5):851-9. PubMed ID: 16033997
[TBL] [Abstract][Full Text] [Related]
16. In vitro targeting of a cytotoxic analog of luteinizing hormone-releasing hormone AN-207 to ES-2 human ovarian cancer cells as demonstrated by microsatellite analyses.
Arencibia JM; Schally AV; Halmos G; Nagy A; Kiaris H
Anticancer Drugs; 2001 Jan; 12(1):71-8. PubMed ID: 11272290
[TBL] [Abstract][Full Text] [Related]
17. Expression of mRNA for luteinizing hormone-releasing hormone receptors and epidermal growth factor receptors in human cancer cell lines.
Lamharzi N; Halmos G; Armatis P; Schally AV
Int J Oncol; 1998 Mar; 12(3):671-5. PubMed ID: 9472110
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of the cytotoxic luteinizing hormone-releasing hormone analog AN-152 on human endometrial and ovarian cancers xenografted into nude mice.
Gründker C; Völker P; Griesinger F; Ramaswamy A; Nagy A; Schally AV; Emons G
Am J Obstet Gynecol; 2002 Sep; 187(3):528-37. PubMed ID: 12237622
[TBL] [Abstract][Full Text] [Related]
19. LH-RH analogue carrying a cytotoxic radical is internalized by rat pituitary cells in vitro.
Szöke B; Horváth J; Halmos G; Rékási Z; Groot K; Nagy A; Schally AV
Peptides; 1994; 15(2):359-66. PubMed ID: 8008640
[TBL] [Abstract][Full Text] [Related]
20. Effective treatment of experimental human endometrial cancers with targeted cytotoxic luteinizing hormone-releasing hormone analogues AN-152 and AN-207.
Engel JB; Keller G; Schally AV; Nagy A; Chism DD; Halmos G
Fertil Steril; 2005 Apr; 83 Suppl 1():1125-33. PubMed ID: 15831285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
